
COMMENTARY: When an HIV scientific breakthrough isn’t enough
A landmark breakthrough in HIV prevention -- a scientific feat decades in the making -- received final approval from the Food and Drug Administration last month. Gilead Sciences' lenacapavir is so effective that global health leaders had started to …